chlorpheniramine has been researched along with Carcinoma, Renal Cell in 1 studies
Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
Excerpt | Relevance | Reference |
---|---|---|
" In study 2 the AMT dosage was increased up to 4-fold by doubling individual doses and switching to a twice daily schedule." | 1.36 | Anti-tumor effects of AMT in the renal cell carcinoma model. ( Caballero, M; Diergarten, K; Drevs, J; Esser, N; Rentschler, J; Schächtele, C; Scheele, J; Soltau, J; Zirrgiebel, U, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caballero, M | 1 |
Scheele, J | 1 |
Zirrgiebel, U | 1 |
Esser, N | 1 |
Schächtele, C | 1 |
Soltau, J | 1 |
Rentschler, J | 1 |
Diergarten, K | 1 |
Drevs, J | 1 |
1 other study available for chlorpheniramine and Carcinoma, Renal Cell
Article | Year |
---|---|
Anti-tumor effects of AMT in the renal cell carcinoma model.
Topics: Animals; Antineoplastic Agents; Calcium; Carcinoma, Renal Cell; Cell Line, Tumor; Chlorpheniramine; | 2010 |